Unimech Aerospace and Manufacturing has completed its first capital infusion of SAR 30 million into its joint venture, Kanoo Unimech Advanced Manufacturing Solutions. Unimech’s share of SAR 15.30 million (approx. Rs 39.35 crore) secures a 51% controlling stake. The venture aims to build a greenfield facility in Dammam, Saudi Arabia, targeting the oil, gas, and defense sectors as part of the company's international expansion strategy.
Unimech Aerospace Completes First Tranche for Saudi JV
Unimech Aerospace has deployed SAR 15.30 million (approx. Rs 39.35 crore) for a 51% stake in its Saudi joint venture.
The total first tranche funding reached SAR 30 million, with partner Yusuf Bin Ahmed Kanoo contributing the remaining 49%.
Reader Takeaway: This capital deployment kickstarts Unimech’s international expansion into Saudi Arabia’s specialized manufacturing and engineering services market.
What just happened
Unimech Aerospace and Manufacturing Limited has officially fulfilled its first tranche of capital commitment to Kanoo Unimech Advanced Manufacturing Solutions. This follows the joint venture agreement signed on January 20, 2026. The investment secures a controlling 51% equity interest for Unimech, while partner Yusuf Bin Ahmed Kanoo Company Limited holds the remaining 49%. Both parties contributed their respective shares to reach the total SAR 30 million initial funding goal.
Why this matters
The funding marks a transition from boardroom agreement to tangible asset development. The joint venture is tasked with constructing a greenfield advanced machining and remanufacturing facility in Dammam, Saudi Arabia. By establishing a local presence, Unimech aims to capture demand for precision engineering within the Kingdom’s energy, defense, and mining sectors, aligning with regional localization mandates.
Risks to watch
The project is currently in its nascent stage; the business has not yet commenced operations or generated turnover. Shareholders should note that a second funding tranche of equal total value (SAR 30 million) is pending. Success depends on the timely commissioning of the Dammam facility and the ability to convert regional localization demand into operational revenue.
What to track next
Investors should monitor upcoming disclosures regarding the progress of the Dammam facility construction and the schedule for the second capital infusion tranche. The operational commencement date will be a key performance indicator for this international expansion.